Overview

Secondary Prophylaxis of Gastric Variceal Bleed

Status:
Completed
Trial end date:
2019-01-07
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to study the efficacy of endoscopic cyanoacrylate injection versus balloon-occluded retrograde transvenous obliteration in the prevention of gastric variceal rebleeding and improvement in survival.
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
West China Hospital
Treatments:
Polidocanol
Criteria
Inclusion Criteria:

1. Cirrhosis

2. Patients who had bled from GOV2 or IGV1(≥5 days and ≤ 28days)

3. Presence of gastrorenal shunt

Exclusion Criteria:

1. Previous treatment of gastric varices, including endoscopic therapy, NSBB, TIPS, or
surgery

2. Non-cirrhotic portal hypertension

3. Contraindications to cyanoacrylate injection or BRTO

4. Portal cavernoma

5. Hepatorenal syndrome

6. Proven malignancy including hepatocellular carcinoma

7. End-stage renal disease under renal replacement therapy;

8. Cardiorespiratory failure

9. Pregnancy or patients not giving informed consent for endoscopic procedures